A Comparison of the Costs and Benefits of Recombinant Human...

A Comparison of the Costs and Benefits of Recombinant Human Erythropoietin (Epoetin) in the Treatment of Chronic Renal Failure in 5 European Countries

Dr Brenda Leese,John Hutton,Alan Maynard
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
1
Language:
english
Journal:
PharmacoEconomics
DOI:
10.2165/00019053-199201050-00006
Date:
May, 1992
File:
PDF, 1021 KB
english, 1992
Conversion to is in progress
Conversion to is failed